Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Hautala, Tapani
DOB: 14-MAY-1952 (Age: 73)
Gender: male
ID: 6930-366204-8 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 16-JUL-2025

Problem list

Condition Onset Date Status
Non-small cell lung cancer 29-May-2024 active
Ischemic heart disease 29-Jun-2021 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 21-Jul-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 28-Jun-2021
SARS-CoV-2 mRNA vaccine 12-Apr-2021
Streptococcus pneumoniae Danish serotype 1 30-May-2016

Procedure History list

Procedure Date Reason
Digital examination of rectum 16-Jul-2025 -
Combined chemotherapy and radiation therapy 30-Jun-2025 Non-small cell carcinoma of lung TNM stage 1 (disorder)
Patient discharge 02-May-2025 -
Hospice care 01-May-2025 -
Notifications 04-Mar-2025 -
Certification procedure 04-Mar-2025 -
Initial patient assessment 04-Mar-2025 -
Development of individualized plan of care 04-Mar-2025 -
Bone immobilization 27-Oct-2024 Fracture of rib
Bone density scan 27-Oct-2024 Fracture of rib
Plain X-ray of chest 27-Oct-2024 -
Pre-discharge assessment 23-Dec-2018 -
Discharge from skilled nursing facility (procedure) 23-Dec-2018 -
Professional / ancillary services care 22-Dec-2018 -
Nursing care/supplementary surveillance 22-Dec-2018 -
Occupational therapy 01-Dec-2018 -
History AND physical examination 28-Nov-2018 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Terminal care 31-May-2024 Non-small cell carcinoma of lung TNM stage 1 (disorder)
  • Ensure patient comfort and symptom control during terminal care phase of non-small cell lung cancer.
  • Maintain pain at or below patient-acceptable level during terminal care.
  • Minimize shortness of breath to improve quality of life during terminal care.
  • Reduce anxiety to a manageable level during terminal care.
  • Ensure care is aligned with patient’s values and preferences, preserving dignity at end of life.
Care plan 06-Mar-2001 -
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-07-21 2024-07-15
Body Height 171.8 cm 171.8 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} 4 {score}
Body Weight 73 kg 73 kg
Body mass index (BMI) [Ratio] 24.7 kg/m2 24.7 kg/m2
Diastolic Blood Pressure 63 mm[Hg] 57 mm[Hg]
Systolic Blood Pressure 89 mm[Hg] 85 mm[Hg]
Heart rate 92 /min 61 /min
Respiratory rate 15 /min 16 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 16-JUL-2025 Reference Range Unit
Prostate specific Ag [Mass/volume] in Serum or Plasma 1.6 0 - 4 ng/mL